Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Creasey

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Circulatory Shock|February 1, 1991
Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coliA A Creasey, P Stevens, J Kenney, et al.
Infection and Immunity|October 1, 1993
Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation patternJ P de Boer, A A Creasey, A Chang, et al.
Hybridoma|August 1, 1987
Murine monoclonal antibodies defining neutralizing epitopes on tumor necrosis factorB M Fendly, K J Toy, A A Creasey, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicinC Dollbaum, A A Creasey, S H Dairkee, et al.
Science (New York, N.Y.)|April 12, 1985
Molecular cloning of the complementary DNA for human tumor necrosis factorA M Wang, A A Creasey, M B Ladner, et al.
Infection and Immunity|December 1, 1993
Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon modelJ P de Boer, A A Creasey, A Chang, et al.
Shock (Augusta, Ga.)|October 27, 1998
Randomized, blinded, placebo-controlled trial of tissue factor pathway inhibitor in porcine septic shockR D Goldfarb, D Glock, K Johnson, et al.
Cancer Research|April 1, 1988
Functional properties of proteins coded by three human alpha-interferon genes and a pseudogeneA A Creasey, C R Vitt, C Herst, et al.
Blood|February 9, 2000
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemiaE de Jonge, P E Dekkers, A A Creasey, et al.
The Journal of Infectious Diseases|May 24, 2001
Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemiaE de Jonge, P E Dekkers, A A Creasey, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Circulatory Shock|February 1, 1991
Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coliA A Creasey, P Stevens, J Kenney, et al.
Infection and Immunity|October 1, 1993
Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation patternJ P de Boer, A A Creasey, A Chang, et al.
Hybridoma|August 1, 1987
Murine monoclonal antibodies defining neutralizing epitopes on tumor necrosis factorB M Fendly, K J Toy, A A Creasey, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicinC Dollbaum, A A Creasey, S H Dairkee, et al.
Science (New York, N.Y.)|April 12, 1985
Molecular cloning of the complementary DNA for human tumor necrosis factorA M Wang, A A Creasey, M B Ladner, et al.
Infection and Immunity|December 1, 1993
Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon modelJ P de Boer, A A Creasey, A Chang, et al.
Shock (Augusta, Ga.)|October 27, 1998
Randomized, blinded, placebo-controlled trial of tissue factor pathway inhibitor in porcine septic shockR D Goldfarb, D Glock, K Johnson, et al.
Cancer Research|April 1, 1988
Functional properties of proteins coded by three human alpha-interferon genes and a pseudogeneA A Creasey, C R Vitt, C Herst, et al.
Blood|February 9, 2000
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemiaE de Jonge, P E Dekkers, A A Creasey, et al.
The Journal of Infectious Diseases|May 24, 2001
Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemiaE de Jonge, P E Dekkers, A A Creasey, et al.
Pageof 4